索性脊髄症の英語

癌及び多発性硬化症（ＭＳ）、ハンチントン病（ＨＤ）、脊髄性筋萎縮症（ＳＭＡ）、球脊髄性筋萎縮症（ＳＢＭＡ）、および筋萎縮性側索硬化症（ＡＬＳ）などの神経変成疾患を治療するためのＨＤＡＣ阻害剤の提供。例文帳に追加

To provide an HDAC inhibitor for treating neurodegenerative diseases such as cancer, multiple sclerosis (MS), Huntington's disease (HD), spinal muscular atrophy (SMA), spinobulbar muscular atrophy (SBMA) and amyotrophic lateral sclerosis (ALS), etc. - 特許庁

治療的に有効な量のＦＴＹ７２０化合物を被験体に投与する工程を包含する、神経障害（パーキンソン病、振せん麻痺障害、ハンティングトン病、アルツハイマー病、筋萎縮性側索硬化症、脊髄虚血、虚血性脳卒中、脊髄損傷、癌関連脳損傷、癌関連脊髄損傷およびシャイ−ドレーガー症候群など）の予防または処置のための方法もまた開示される。例文帳に追加

There is also provided a method for preventing or treating neurological disorders, including Parkinson's disease, paralysis agitans, Huntington's disease, Alzheimer's disease, amyotrophic lateral sclerosis, spinal cord ischaemia, ischemic stroke, spinal cord injury, brain damage associated with cancer, spinal cord injury associated with cancer, and Shy-Drager syndrome, or the like, comprising a step of administering to a subject a therapeutically effective amount of a FTY720 compound. - 特許庁

筋萎縮性側索硬化症（ＡＬＳ）、脊髄性筋萎縮症候群（ＳＭＡ）、ハンチントン病、パーキンソン病、アルツハイマー病、脳血管障害後の痴呆、その他の神経脱落を伴なう痴呆症等の神経変性疾患の治療及び予防に有用な薬剤を提供する。例文帳に追加

To obtain an agent useful for treatment and prophylaxis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), Huntington's disease, Parkinson's disease, Alzheimer's disease, dementia after cerebrovascular disorders or other dementias accompanied with nerve deciduation. - 特許庁

強力な非ＮＭＤＡ拮抗特性を有し、脳血管発作、脳または脊髄の外傷、癩癇、アルツハイマー病などの慢性神経変性疾患、精神分裂病、筋萎縮性側索硬化症またはハンチントン舞踏病の治療に有用で腎毒性が低い新規化合物の提供。例文帳に追加

To obtain a novel compound that has strong non-NMD antagonistic properties, is useful for treatment of cerebral blood vessel attack, external wound in brain and vertebra, epilepsy, chromatic neurodegenerative diseases, for example, Alzheimer's disease, schizophrenia, amyotrophic lateral sclerosis or Huntington's chorea with reduced nephrotoxicity. - 特許庁

強力な非ＮＭＤＡアンタゴニスト性を有し、脳血管障害のような変性障害、脳性若しくは脊髄性外傷、てんかん、アルツハイマー病のような慢性神経変性疾患、精神分裂症、筋萎縮性側索硬化症又はハンチントン舞踏病の、急性治療、及び特に慢性治療に有用な新規な化合物の提供。例文帳に追加

To provide a new compound which has a strong non-NMDA antagonist property, and is useful for the acute and especially chronic treatments of degenerative disorders such as cerebrovascular disorder, chronic neurodegenerative disorders such as cerebral or spinal trauma, epilepsy and Alzheimer's disease, schizophrenia, amyotrophic lateral sclerosis and Huntington's chorea. - 特許庁